Delivery Order SPE2DB22D9239-SPE2DB25FDG89

Award Date 2/26/25
Potential Completion Date 3/19/25
Potential Value $82K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $80,285.70, is a firm fixed-price delivery order for the supply of Keytruda 100 mg/4 ml vials. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm...
This federal contract award, valued at $81,895.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,567,379,133 units of Keytruda 100 mg/4 mL vial (4 mL). This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program,...
This federal contract award, with ID SPE2DX15D9114|SPE2DX23F6ACR, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a $77,505.20 firm fixed-price delivery order for 4,561,324,823 units of the pharmaceutical drug Keytruda (100 mg/4 ml vial, 4 ml). DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $155,010.40 contract is for the delivery of Keytruda 100 mg/4 ml vials and has an ultimate completion date of August 2, 2023. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $93,006.24 for the provision of Keytruda 100 mg/4 ml vials. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables DLA to issue...
This federal contract award, valued at $155,010.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to provide 4,560,628,825 units of the prescription drug Keytruda (100 mg/4 ml vial, 4 ml) to support the medical supply needs of military healthcare facilities. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $40,142.85, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Keytruda 100 mg/4 ml vial, a cancer treatment drug, with an ultimate completion date of October 17, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $77,505.20 contract is for the provision of 4,560,982,416 units of the prescription drug Keytruda (100 mg/4 ml vial, 4 ml) to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $56,012.64, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Keytruda 100 mg/4 ml vials, with an ultimate completion date of August 19, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $80,218.40 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vials and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDG89
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $81,895.60, is a firm fixed-price delivery order for the procurement of 4,567,422,449 units of the drug Keytruda (100 mg/4 ml vial, 4 ml). The contract has an ultimate completion date of March 19, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract award is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. The company also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products.

Generated 5/28/25, 10:47 AM